Where I see patients (1)
My reviews
5.0
Selected research
-
Lower leukemia burden maximizes the impact of blinatumomab therapy.
Cancer
-
Sequencing Antigen-Targeting Antibodies and Cellular Therapies in Adults With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia.
American journal of hematology
-
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
Journal of hematology & oncology
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421